The Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts
The Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts
分析师意见：爱美医疗在8位专家眼中
The perception of Amicus...In the preceding three months, 8 analysts have released ratings for Amicus Therapeutics (NASDAQ:FOLD), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，已有8位分析师为Amicus Therapeutics（纳斯达克：FOLD）发布了评级，展示了从看好到看淡的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.5, a high estimate of $21.00, and a low estimate of $15.00. Observing a 3.8% increase, the current average has risen from the previous average price target of $16.86.
分析师通过其对12个月价格目标的评估提供更深入的见解，显示平均目标为17.5美元，最高估值为21.00美元，最低估值为15.00美元。观察到3.8%的增长，当前平均数已从之前的16.86美元上升。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
The perception of Amicus...
爱美医疗...
登录免费看全文
登录/注册
热门讨论
中概股财报季火热：惊喜盈利能否延续涨势？
1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？
Moomoo News Global
03/04 23:26
中国两会：会议前后股票价格走势的主要要点